SCHEMBL19494346

SCHEMBL19494346

COC1CCN(Sc2cc(C(N)=O)c(NC(=O)c3ccccc3F)s2)CC1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.41
▸ NPC1 O15118 5/20 0.41
▸ KDM4E B2RXH2 5/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ RORC P51449 2/20 0.38
▸ IKBKB O14920 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494889 0.85 NPC1 (0.48) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494684 0.84 NPC1 (0.46) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494434 0.82 NPC1 (0.45) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494717 0.81 NPC1 (0.46) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494691 0.81 IKBKB (0.36) IKBKB
SCHEMBL16263746 0.81 CFTR (0.48) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494637 0.81 NPC1 (0.45) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494729 0.79 NPC1 (0.42) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494506 0.78 NPC1 (0.49) RAB9ANPC1KDM4EALDH1A1LMNA
SCHEMBL19494688 0.77 MAPT (0.52) RAB9ANPC1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback